Normotension, hypertension and body fluid regulation: brain and kidney

Acta Physiologica

Volumn 219, Issue 1, 2017, Pages 288-304

  Bie, P ^a,b   Evans, R G ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b MONASH UNIVERSITY   (Australia)

Author keywords

blood pressure; hypertension; neurocentric; pressure natriuresis; renocentric; sympathetic tone

Indexed keywords

NORADRENALIN; RENIN; SODIUM;

ARTERIAL PRESSURE; BLOOD PRESSURE REGULATION; BODY FLUID; CATECHOLAMINE BLOOD LEVEL; ESSENTIAL HYPERTENSION; HUMAN; KIDNEY NERVE; NATRIURESIS; NEUROGRAPHY; NONHUMAN; PLASMA RENIN ACTIVITY; PRESSORECEPTOR; PRIORITY JOURNAL; RENIN RELEASE; REVIEW; SODIUM INTAKE; SODIUM URINE LEVEL; SYMPATHETIC TONE; BLOOD PRESSURE; BRAIN; HOMEOSTASIS; HYPERTENSION; KIDNEY; PATHOPHYSIOLOGY; PHYSIOLOGY;

BLOOD PRESSURE; BODY FLUIDS; BRAIN; HOMEOSTASIS; HUMANS; HYPERTENSION; KIDNEY;

EID: 84977108892     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/apha.12718     Document Type: Review

References (151)

1. Andersen, L.J., Norsk, P., Johansen, L.B., Christensen, P., Engstrom, T. & Bie, P. 1998. Osmoregulatory control of renal sodium excretion after sodium loading in humans. Am J Physiol 275, R1833–R1842.
2. Andersen, L.J., Jensen, T.U., Bestle, M.H. & Bie, P. 1999. Isotonic and hypertonic sodium loading in supine humans. Acta Physiol Scand 166, 23–30.
3. Andersen, J.L., Andersen, L.J., Sandgaard, N.C. & Bie, P. 2000. Volume expansion natriuresis during servo control of systemic blood pressure in conscious dogs. Am J Physiol Regul Integr Comp Physiol 278, R19–R27.
4. Andersen, L.J., Andersen, J.L., Pump, B. & Bie, P. 2002. Natriuresis induced by mild hypernatremia in humans. Am J Physiol Regul Integr Comp Physiol 282, R1754–R1761.
5. Baldes, E.J. & Smirk, F.H. 1934. The effect of water drinking, mineral starvation and salt administration on the total osmotic pressure of the blood in man, chiefly in relation to the problems of water absorption and water diuresis. J Physiol 82, 62–74.
6. Barrett, C.J. 2015. Renal sympathetic nerves – what have they got to do with cardiovascular disease? Exp Physiol 100, 359–365.
7. Beard, D.A. 2013. Tautology vs. physiology in the etiology of hypertension. Physiology (Bethesda) 28, 270–271.
8. Bie, P. 2009. Blood volume, blood pressure and total body sodium: internal signalling and output control. Acta Physiol (Oxf) 195, 187–196.
9. Bie, P., Wamberg, S. & Kjolby, M. 2004. Volume natriuresis vs. pressure natriuresis. Acta Physiol Scand 181, 495–503.
10. Bie, P., Molstrom, S. & Wamberg, S. 2009. Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade. Am J Physiol Regul Integr Comp Physiol 296, R428–R435.
11. Blaustein, M.P., Leenen, F.H., Chen, L., Golovina, V.A., Hamlyn, J.M., Pallone, T.L., Van Huysse, J.W., Zhang, J. & Wier, W.G. 2012. How NaCl raises blood pressure: a new paradigm for the pathogenesis of salt-dependent hypertension. Am J Physiol Heart Circ Physiol 302, H1031–H1049.
12. Borst, J.G. & Borst-De Geus, A. 1963. Hypertension explained by Starling's theory of circulatory homoeostasis. Lancet 1, 677–682.
13. Brands, M.W. 2012. Chronic blood pressure control. Compr Physiol 2, 2481–2494.
14. Brown, J.J., Davies, D.L., Lever, A.F. & Robertson, J.I. 1964. Variations in plasma renin concentration in several physiological and pathological states. Can Med Assoc J 90, 201–206.
15. Brunner, H.R., Laragh, J.H., Baer, L., Newton, M.A., Goodwin, F.T., Krakoff, L.R., Bard, R.H. & Buhler, F.R. 1972. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med 286, 441–449.
16. Carretero, O.A. & Oparil, S. 2000. Essential hypertension. Part I: definition and etiology. Circulation 101, 329–335.
17. Charkoudian, N. & Wallin, B.G. 2014. Sympathetic neural activity to the cardiovascular system: integrator of systemic physiology and interindividual characteristics. Compr Physiol 4, 825–850.
18. Charkoudian, N., Joyner, M.J., Johnson, C.P., Eisenach, J.H., Dietz, N.M. & Wallin, B.G. 2005. Balance between cardiac output and sympathetic nerve activity in resting humans: role in arterial pressure regulation. J Physiol 568, 315–321.
19. Charkoudian, N., Joyner, M.J., Sokolnicki, L.A., Johnson, C.P., Eisenach, J.H., Dietz, N.M., Curry, T.B. & Wallin, B.G. 2006. Vascular adrenergic responsiveness is inversely related to tonic activity of sympathetic vasoconstrictor nerves in humans. J Physiol 572, 821–827.
20. Chobanian, A.V., Bakris, G.L., Black, H.R., Cushman, W.C., Green, L.A., Izzo, J.L. Jr, Jones, D.W., Materson, B.J., Oparil, S., Wright, J.T. Jr, Roccella, E.J., Joint National Committee on Prevention D. E., Treatment of High Blood Pressure, National Heart L., Blood I. & National High Blood Pressure Education Program Coordinating C. 2003. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206–1252.
21. Coffman, T.M. 2011. Under pressure: the search for the essential mechanisms of hypertension. Nat Med 17, 1402–1409.
22. Coffman, T.M. & Crowley, S.D. 2008. Kidney in hypertension: guyton redux. Hypertension 51, 811–816.
23. Conn, J.W., Rovner, D.R. & Cohen, E.L. 1965. Normal and altered function of the renin-angiotensin-aldosterone system in man: applications in clinical and research medicine. Ann Intern Med 63, 266–284.
24. Conway, J. 1963. Current concepts concerning the etiology of essential hypertension. Am Heart J 66, 409–413.
25. Crowley, S.D. & Coffman, T.M. 2014. The inextricable role of the kidney in hypertension. J Clin Invest 124, 2341–2347.
26. Dahl, L.K. 1958a. Salt intake and salt need. N Engl J Med 258, 1152–1157 contd.
27. Dahl, L.K. 1958b. Sodium intake of the American male: implications on the etiology of essential hypertension. Am J Clin Nutr 6, 1–7.
28. Dahl, L.K. 1960. Possible role of salt in the development of essential hypertension. In: K.D. Bock & P.T. Cottier (eds) Essential Hypertension, pp. 53–65. Springer-Verlag, Berlin.
29. Dahl, L.K., Heine, M. & Thompson, K. 1974. Genetic influence of the kidneys on blood pressure. Evidence from chronic renal homografts in rats with opposite predispositions to hypertension. Circ Res 40, 94–101.
30. Damgaard, M., Gabrielsen, A., Heer, M., Warberg, J., Bie, P., Christensen, N.J. & Norsk, P. 2002. Effects of sodium intake on cardiovascular variables in humans during posture changes and ambulatory conditions. Am J Physiol Regul Integr Comp Physiol 283, R1404–R1411.
31. Damgaard, M., Norsk, P., Gustafsson, F., Kanters, J.K., Christensen, N.J., Bie, P., Friberg, L. & Gadsboll, N. 2006. Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 290, R1294–R1301.
32. Damkjaer, M., Isaksson, G.L., Stubbe, J., Jensen, B.L., Assersen, K. & Bie, P. 2013. Renal renin secretion as regulator of body fluid homeostasis. Pflugers Arch 465, 153–165.
33. Damkjaer, M., Jensen, P.H., Schwammle, V., Sprenger, R.R., Jacobsen, I.A., Jensen, O.N. & Bie, P. 2014. Selective renal vasoconstriction, exaggerated natriuresis and excretion rates of exosomic proteins in essential hypertension. Acta Physiol (Oxf) 212, 106–118.
34. Davies, D.F. & Shock, N.W. 1950. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 29, 496–507.
35. DeClue, J.W., Guyton, A.C., Cowley, A.W. Jr, Coleman, T.G., Norman, R.A. Jr & McCaa, R.E. 1978. Subpressor angiotensin infusion, renal sodium handling, and salt-induced hypertension in the dog. Circ Res 43, 503–512.
36. Denton, D.A. 1984. The Hunger for Salt. An Anthropological, Physiological and Medical Analysis. Springer-Verlag, Berlin, Heidelberg, New York, NY, Tokyo.
37. DeQuattro, V. & Miura, Y. 1973. Neurogenic factors in human hypertension: mechanism or myth? Am J Med 55, 362–378.
38. DiBona, G.F. & Kopp, U.C. 1997. Neural control of renal function. Physiol Rev 77, 75–197.
39. DuPont, J.J., Greaney, J.L., Wenner, M.M., Lennon-Edwards, S.L., Sanders, P.W., Farquhar, W.B. & Edwards, D.G. 2013. High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens 31, 530–536.
40. Engelman, K. & Portnoy, B. 1970. A sensitive double-isotope derivative assay for norepinephrine and epinephrine. Normal resting human plasma levels. Circ Res 26, 53–57.
41. Esler, M. 2014. Sympathetic nervous system moves toward center stage in cardiovascular medicine: from Thomas Willis to resistant hypertension. Hypertension 63, e25–e32.
42. Esler, M. 2015. The sympathetic nervous system in hypertension: back to the future? Curr Hypertens Rep 17, 11.
43. Esler, M., Julius, S., Zweifler, A., Randall, O., Harburg, E., Gardiner, H. & DeQuattro, V. 1977. Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med 296, 405–411.
44. Esler, M., Jackman, G., Bobik, A., Kelleher, D., Jennings, G., Leonard, P., Skews, H. & Korner, P. 1979. Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25, 1461–1470.
45. Esler, M., Jennings, G., Korner, P., Blombery, P., Burke, F., Willett, I. & Leonard, P. 1984a. Total, and organ-specific, noradrenaline plasma kinetics in essential hypertension. Clin Exp Hypertens A 6, 507–521.
46. Esler, M., Jennings, G., Korner, P., Blombery, P., Sacharias, N. & Leonard, P. 1984b. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol 247, E21–E28.
47. Esler, M., Willett, I., Leonard, P., Hasking, G., Johns, J., Little, P. & Jennings, G. 1984c. Plasma noradrenaline kinetics in humans. J Auton Nerv Syst 11, 125–144.
48. Esler, M., Jennings, G., Biviano, B., Lambert, G. & Hasking, G. 1986. Mechanism of elevated plasma noradrenaline in the course of essential hypertension. J Cardiovasc Pharmacol 8(Suppl 5), S39–S43.
49. Esler, M., Jennings, G., Korner, P., Willett, I., Dudley, F., Hasking, G., Anderson, W. & Lambert, G. 1988. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11, 3–20.
50. Esler, M., Jennings, G. & Lambert, G. 1989a. Noradrenaline release and the pathophysiology of primary human hypertension. Am J Hypertens 2, 140S–146S.
51. Esler, M., Lambert, G. & Jennings, G. 1989b. Regional norepinephrine turnover in human hypertension. Clin Exp Hypertens A 11(Suppl 1), 75–89.
52. Esler, M., Jennings, G., Lambert, G., Meredith, I., Horne, M. & Eisenhofer, G. 1990. Overflow of catecholamine neurotransmitters to the circulation: source, fate, and functions. Physiol Rev 70, 963–985.
53. Esler, M., Lambert, E. & Schlaich, M. 2010. Point: chronic activation of the sympathetic nervous system is the dominant contributor to systemic hypertension. J Appl Physiol 109, 1996–1998; discussion 2016.
54. Evans, R.G. & Bie, P. 2016. The role of the kidney in the pathogenesis of hypertension: time for a neo-Guytonian paradigm or a paradigm shift? Am J Physiol Regul Integr Comp Physiol 310, R217–R229.
55. Fagius, J. & Wallin, B.G. 1993. Long-term variability and reproducibility of resting human muscle nerve sympathetic activity at rest, as reassessed after a decade. Clin Auton Res 3, 201–205.
56. Fisher, J.P. & Paton, J.F. 2012. The sympathetic nervous system and blood pressure in humans: implications for hypertension. J Hum Hypertens 26, 463–475.
57. Fisher, N.D., Hurwitz, S., Ferri, C., Jeunemaitre, X., Hollenberg, N.K. & Williams, G.H. 1999. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension 34, 388–394.
58. Folkow, B. 1982. Physiological aspects of primary hypertension. Physiol Rev 62, 347–504.
59. Folkow, B., Di Bona, G.F., Hjemdahl, P., Toren, P.H. & Wallin, B.G. 1983. Measurements of plasma norepinephrine concentrations in human primary hypertension. A word of caution on their applicability for assessing neurogenic contributions. Hypertension 5, 399–403.
60. Friberg, P., Meredith, I., Jennings, G., Lambert, G., Fazio, V. & Esler, M. 1990. Evidence for increased renal norepinephrine overflow during sodium restriction in humans. Hypertension 16, 121–130.
61. Gabrielsen, A., Bie, P., Holstein-Rathlou, N.H., Christensen, N.J., Warberg, J., Dige-Petersen, H., Frandsen, E., Galatius, S., Pump, B., Sorensen, V.B., Kastrup, J. & Norsk, P. 2001. Neuroendocrine and renal effects of intravascular volume expansion in compensated heart failure. Am J Physiol Regul Integr Comp Physiol 281, R459–R467.
62. Goldstein, D.S., Horwitz, D., Keiser, H.R., Polinsky, R.J. & Kopin, I.J. 1983a. Plasma l-[3H]norepinephrine, d-[14C]norepinephrine, and d, l-[3H]isoproterenol kinetics in essential hypertension. J Clin Invest 72, 1748–1758.
63. Goldstein, D.S., McCarty, R., Polinsky, R.J. & Kopin, I.J. 1983b. Relationship between plasma norepinephrine and sympathetic neural activity. Hypertension 5, 552–559.
64. Grassi, G. 2010. Sympathetic neural activity in hypertension and related diseases. Am J Hypertens 23, 1052–1060.
65. Grassi, G., Mark, A. & Esler, M. 2015. The sympathetic nervous system alterations in human hypertension. Circ Res 116, 976–990.
66. Greenwood, J.P., Stoker, J.B. & Mary, D.A. 1999. Single-unit sympathetic discharge: quantitative assessment in human hypertensive disease. Circulation 100, 1305–1310.
67. Guyton, A.C. & Coleman, T.G. 1969. Quantitative analysis of the pathophysiology of hypertension. Circ Res 24, 1–19.
68. Guyton, A.C., Coleman, T.G., Cowley, A.V. Jr, Scheel, K.W., Manning, R.D. Jr & Norman, R.A. Jr 1972a. Arterial pressure regulation. Overriding dominance of the kidneys in long-term regulation and in hypertension. Am J Med 52, 584–594.
69. Guyton, A.C., Coleman, T.G., Cowley, A.W. Jr, Liard, J.F., Norman, R.A. Jr & Manning, R.D. Jr 1972b. Systems analysis of arterial pressure regulation and hypertension. Ann Biomed Eng 1, 254–281.
70. Guyton, A.C., Cowley, A.W.J., Young, D.B., Coleman, T.G., Hall, J.E. & DeClue, J.W. 1976. Integration of control of circulatory function. In: A.C. Guyton & A.W. Cowley Jr (eds) International Review of Physiology. Cardiovascular Physiology, pp. 341–385. University Park Press, Baltimore, MD.
71. Hagbarth, K.E. & Vallbo, A.B. 1968. Pulse and respiratory grouping of sympathetic impulses in human muscle-nerves. Acta Physiol Scand 74, 96–108.
72. Hall, J.E. 2003. The kidney, hypertension, and obesity. Hypertension 41, 625–633.
73. Hall, J.E., Guyton, A.C., Smith, M.J. Jr & Coleman, T.G. 1980. Blood pressure and renal function during chronic changes in sodium intake: role of angiotensin. Am J Physiol 239, F271–F280.
74. Hall, J.E., Granger, J.P., Smith, M.J. Jr & Premen, A.J. 1984. Role of renal hemodynamics and arterial pressure in aldosterone “escape”. Hypertension 6, I183–I192.
75. Hall, J.E., Granger, J.P., do Carmo, J.M., da Silva, A.A., Dubinion, J., George, E., Hamza, S., Speed, J. & Hall, M.E. 2012. Hypertension: physiology and pathophysiology. Compr Physiol 2, 2393–2442.
76. Hall, M.E., do Carmo, J.M., da Silva, A.A., Juncos, L.A., Wang, Z. & Hall, J.E. 2014. Obesity, hypertension, and chronic kidney disease. Int J Nephrol Renovasc Dis 7, 75–88.
77. Hart, E.C., Charkoudian, N., Wallin, B.G., Curry, T.B., Eisenach, J.H. & Joyner, M.J. 2009. Sex differences in sympathetic neural-hemodynamic balance: implications for human blood pressure regulation. Hypertension 53, 571–576.
78. Hart, E.C., Charkoudian, N., Wallin, B.G., Curry, T.B., Eisenach, J. & Joyner, M.J. 2011. Sex and ageing differences in resting arterial pressure regulation: the role of the beta-adrenergic receptors. J Physiol 589, 5285–5297.
79. He, F.J., Markandu, N.D. & MacGregor, G.A. 2001. Importance of the renin system for determining blood pressure fall with acute salt restriction in hypertensive and normotensive whites. Hypertension 38, 321–325.
80. He, F.J., Li, J. & MacGregor, G.A. 2013. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev 4, CD004937.
81. Heer, M., Frings-Meuthen, P., Titze, J., Boschmann, M., Frisch, S., Baecker, N. & Beck, L. 2009. Increasing sodium intake from a previous low or high intake affects water, electrolyte and acid-base balance differently. Br J Nutr 101, 1286–1294.
82. Hildebrandt, D.A., Irwin, E.D., Cates, A.W. & Lohmeier, T.E. 2014. Regulation of renin secretion and arterial pressure during prolonged baroreflex activation: influence of salt intake. Hypertension 64, 604–609.
83. Huby, A.C., Antonova, G., Groenendyk, J., Gomez-Sanchez, C.E., Bollag, W.B., Filosa, J.A. & Belin de Chantemele, E.J. 2015. The adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis. Circulation 132, 2134–2145.
84. Iliescu, R., Tudorancea, I. & Lohmeier, T.E. 2014. Baroreflex activation: from mechanisms to therapy for cardiovascular disease. Curr Hypertens Rep 16, 453.
85. Institute of Medicine (IOM) 2013. Sodium Intake in Populations: Assessment of Evidence. The National Academies Press, Washington, DC.
86. Isaksson, G.L., Stubbe, J., Lyngs Hansen, P., Jensen, B.L. & Bie, P. 2014. Salt sensitivity of renin secretion, glomerular filtration rate and blood pressure in conscious Sprague–Dawley rats. Acta Physiol (Oxf) 210, 446–454.
87. Ivy, J.R. & Bailey, M.A. 2014. Pressure natriuresis and the renal control of arterial blood pressure. J Physiol 592, 3955–3967.
88. James, P.A., Oparil, S., Carter, B.L., Cushman, W.C., Dennison-Himmelfarb, C., Handler, J., Lackland, D.T., LeFevre, M.L., MacKenzie, T.D., Ogedegbe, O. et al. 2014. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 311, 507–520.
89. Jelakovic, B. & Mayer, G. 1995. A renocentric view of essential hypertension: lessons to be learnt from kidney transplantation. Nephrol Dial Transplant 10, 1510–1512.
90. Johansson, M., Elam, M., Rundqvist, B., Eisenhofer, G., Herlitz, H., Jensen, G. & Friberg, P. 2000. Differentiated response of the sympathetic nervous system to angiotensin-converting enzyme inhibition in hypertension. Hypertension 36, 543–548.
91. Johnson, R.J., Feig, D.I., Nakagawa, T., Sanchez-Lozada, L.G. & Rodriguez-Iturbe, B. 2008. Pathogenesis of essential hypertension: historical paradigms and modern insights. J Hypertens 26, 381–391.
92. Joyner, M.J., Charkoudian, N. & Wallin, B.G. 2008. A sympathetic view of the sympathetic nervous system and human blood pressure regulation. Exp Physiol 93, 715–724.
93. Joyner, M.J., Barnes, J.N., Hart, E.C., Wallin, B.G. & Charkoudian, N. 2015. Neural control of the circulation: how sex and age differences interact in humans. Compr Physiol 5, 193–215.
94. Kanellis, J., Nakagawa, T., Herrera-Acosta, J., Schreiner, G.F., Rodriguez-Iturbe, B. & Johnson, R.J. 2003. A single pathway for the development of essential hypertension. Cardiol Rev 11, 180–196.
95. Kjolby, M. & Bie, P. 2008. Chronic activation of plasma renin is log-linearly related to dietary sodium and eliminates natriuresis in response to a pulse change in total body sodium. Am J Physiol Regul Integr Comp Physiol 294, R17–R25.
96. Kjolby, M.J., Kompanowska-Jezierska, E., Wamberg, S. & Bie, P. 2005. Effects of sodium intake on plasma potassium and renin angiotensin aldosterone system in conscious dogs. Acta Physiol Scand 184, 225–234.
97. Kocsis, B., Karlsson, T. & Wallin, B.G. 1999. Cardiac- and noncardiac-related coherence between sympathetic drives to muscles of different human limbs. Am J Physiol 276, R1608–R1616.
98. Kopin, I.J., Rundqvist, B., Friberg, P., Lenders, J., Goldstein, D.S. & Eisenhofer, G. 1998. Different relationships of spillover to release of norepinephrine in human heart, kidneys, and forearm. Am J Physiol 275, R165–R173.
99. Krikken, J.A., Dallinga-Thie, G.M., Navis, G. & Dullaart, R.P. 2012. Short term dietary sodium restriction decreases HDL cholesterol, apolipoprotein A-I and high molecular weight adiponectin in healthy young men: relationships with renal hemodynamics and RAAS activation. Nutr Metab Cardiovasc Dis 22, 35–41.
100. Lansang, M.C. & Hollenberg, N.K. 2000. ACE inhibition and the kidney: species variation in the mechanisms responsible for the renal haemodynamic response. J Renin Angiotensin Aldosterone Syst 1, 119–124.
101. Laragh, J.H. & Sealey, J.E. 2011. The plasma renin test reveals the contribution of body sodium-volume content (V) and renin-angiotensin (R) vasoconstriction to long-term blood pressure. Am J Hypertens 24, 1164–1180.
102. Lichardus, B. 2014. Early stages of the natriuretic hormone story. Front Endocrinol (Lausanne) 5, 180.
103. Lohmeier, T.E. & Iliescu, R. 2011. Chronic lowering of blood pressure by carotid baroreflex activation: mechanisms and potential for hypertension therapy. Hypertension 57, 880–886.
104. Lohmeier, T.E. & Iliescu, R. 2015. The baroreflex as a long-term controller of arterial pressure. Physiology (Bethesda) 30, 148–158.
105. Lohmeier, T.E., Irwin, E.D., Rossing, M.A., Serdar, D.J. & Kieval, R.S. 2004. Prolonged activation of the baroreflex produces sustained hypotension. Hypertension 43, 306–311.
106. Lohmeier, T.E., Hildebrandt, D.A., Warren, S., May, P.J. & Cunningham, J.T. 2005. Recent insights into the interactions between the baroreflex and the kidneys in hypertension. Am J Physiol Regul Integr Comp Physiol 288, R828–R836.
107. Lohmeier, T.E., Hildebrandt, D.A., Dwyer, T.M., Barrett, A.M., Irwin, E.D., Rossing, M.A. & Kieval, R.S. 2007. Renal denervation does not abolish sustained baroreflex-mediated reductions in arterial pressure. Hypertension 49, 373–379.
108. Lohmeier, T.E., Hildebrandt, D.A., Dwyer, T.M., Iliescu, R., Irwin, E.D., Cates, A.W. & Rossing, M.A. 2009. Prolonged activation of the baroreflex decreases arterial pressure even during chronic adrenergic blockade. Hypertension 53, 833–838.
109. Lohmeier, T.E., Iliescu, R., Dwyer, T.M., Irwin, E.D., Cates, A.W. & Rossing, M.A. 2010. Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex. Am J Physiol Heart Circ Physiol 299, H402–H409.
110. Luther, J.M., Byrne, L.M., Yu, C., Wang, T.J. & Brown, N.J. 2014. Dietary sodium restriction decreases insulin secretion without affecting insulin sensitivity in humans. J Clin Endocrinol Metab 99, E1895–E1902.
111. Malpas, S.C. 2010. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev 90, 513–557.
112. Mancia, G. 2015. Introduction to a compendium on hypertension. Circ Res 116, 923–924.
113. Mancia, G. & Grassi, G. 2014. The autonomic nervous system and hypertension. Circ Res 114, 1804–1814.
114. Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A.M., Kjeldsen, S.E., Laurent, S. et al. 2007. 2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 25, 1105–1187.
115. Melander, O., von Wowern, F., Frandsen, E., Burri, P., Willsteen, G., Aurell, M. & Hulthen, U.L. 2007. Moderate salt restriction effectively lowers blood pressure and degree of salt sensitivity is related to baseline concentration of renin and N-terminal atrial natriuretic peptide in plasma. J Hypertens 25, 619–627.
116. Menni, C., Graham, D., Kastenmuller, G., Alharbi, N.H., Alsanosi, S.M., McBride, M., Mangino, M., Titcombe, P., Shin, S.Y., Psatha, M. et al. 2015. Metabolomic identification of a novel pathway of blood pressure regulation involving hexadecanedioate. Hypertension 66, 422–429.
117. Meredith, I.T., Friberg, P., Jennings, G.L., Dewar, E.M., Fazio, V.A., Lambert, G.W. & Esler, M.D. 1991. Exercise training lowers resting renal but not cardiac sympathetic activity in humans. Hypertension 18, 575–582.
118. Messerli, F.H., Williams, B. & Ritz, E. 2007. Essential hypertension. Lancet 370, 591–603.
119. Molstrom, S., Larsen, N.H., Simonsen, J.A., Washington, R. & Bie, P. 2009. Normotensive sodium loading in normal man: regulation of renin secretion during beta-receptor blockade. Am J Physiol Regul Integr Comp Physiol 296, R436–R445.
120. Montani, J.P. & Van Vliet, B.N. 2009. Understanding the contribution of Guyton's large circulatory model to long-term control of arterial pressure. Exp Physiol 94, 382–388.
121. Morganti, A., Lopez-Ovejero, J.A., Pickering, T.G. & Laragh, J.H. 1979. Role of the sympathetic nervous system in mediating the renin response to head-up tilt. Their possible synergism in defending blood pressure against postural changes during sodium deprivation. Am J Cardiol 43, 600–604.
122. Narkiewicz, K., Phillips, B.G., Kato, M., Hering, D., Bieniaszewski, L. & Somers, V.K. 2005. Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity. Hypertension 45, 522–525.
123. Navar, L.G. 2010. Counterpoint: activation of the intrarenal renin-angiotensin system is the dominant contributor to systemic hypertension. J Appl Physiol 109, 1998–2000.
124. O'Brien, E. & Staessen, J.A. 2000. Critical appraisal of the JNC VI, WHO/ISH and BHS guidelines for essential hypertension. Expert Opin Pharmacother 1, 675–682.
125. Oliver, W.J., Cohen, E.L. & Neel, J.V. 1975. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “no-salt” culture. Circulation 52, 146–151.
126. Page, I.H. 1949. Pathogenesis of arterial hypertension. J Am Med Assoc 140, 451–458.
127. Page, I.H. 1960. The mosaic theory of hypertension. In: K.D. Bock & P.T. Cottier (eds) Essential Hypertension, pp. 1–29. Springer Verlag, Berlin.
128. Rasmussen, M.S., Simonsen, J.A., Sandgaard, N.C., Hoilund-Carlsen, P.F. & Bie, P. 2003. Mechanisms of acute natriuresis in normal humans on low sodium diet. J Physiol 546, 591–603.
129. Rasmussen, M.S., Simonsen, J.A., Sandgaard, N.C., Hoilund-Carlsen, P.F. & Bie, P. 2004. Effects of oxytocin in normal man during low and high sodium diets. Acta Physiol Scand 181, 247–257.
130. Rettig, R., Folberth, C., Stauss, H., Kopf, D., Waldherr, R. & Unger, T. 1990. Role of the kidney in primary hypertension: a renal transplantation study in rats. Am J Physiol 258, F606–F611.
131. Rowe, J.W., Andres, R., Tobin, J.D., Norris, A.H. & Shock, N.W. 1976. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31, 155–163.
132. Schlaich, M.P., Hering, D., Sobotka, P., Krum, H., Lambert, G.W., Lambert, E. & Esler, M.D. 2012. Effects of renal denervation on sympathetic activation, blood pressure, and glucose metabolism in patients with resistant hypertension. Front Physiol 3, 10.
133. Simonsen, J.A., Rasmussen, M.S., Vach, W., Hoilund-Carlsen, P.F. & Bie, P. 2012. Exaggerated natriuresis during clamping of systemic NO supply in healthy young men. Clin Sci (Lond) 122, 63–73.
134. Smith, H.W. 1957. Salt and water volume receptors: an exercise in physiologic apologetics. Am J Med 23, 623–652.
135. Stocker, S.D., Lang, S.M., Simmonds, S.S., Wenner, M.M. & Farquhar, W.B. 2015. Cerebrospinal fluid hypernatremia elevates sympathetic nerve activity and blood pressure via the rostral ventrolateral medulla. Hypertension 66, 1184–1190.
136. Sundlof, G. & Wallin, B.G. 1977. The variability of muscle nerve sympathetic activity in resting recumbent man. J Physiol 272, 383–397.
137. Sundlof, G. & Wallin, B.G. 1978. Human muscle nerve sympathetic activity at rest. Relationship to blood pressure and age. J Physiol 274, 621–637.
138. Thorn, N.A. 1960. Total body contents of sodium and potassium. Total exchangeable sodium and potassium. In: O. Eichler & A. Farah (eds) Handbuch der Experimentellen Pharmakologie. Vol. 13. The Alkali Metal Ions in Biology, pp. 226–232. Springer-Verlag, Berlin.
139. Thrasher, T.N. 2004. Baroreceptors and the long-term control of blood pressure. Exp Physiol 89, 331–335.
140. Thrasher, T.N. 2005. Effects of chronic baroreceptor unloading on blood pressure in the dog. Am J Physiol Regul Integr Comp Physiol 288, R863–R871.
141. Tracy, R.E. 2011. Renal vasculature in essential hypertension: a review of some contrarian evidence. Contrib Nephrol 169, 327–336.
142. Tuck, M.L. 1986. The sympathetic nervous system in essential hypertension. Am Heart J 112, 877–886.
143. Vallbo, A.B., Hagbarth, K.E. & Wallin, B.G. 2004. Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system. J Appl Physiol 96, 1262–1269.
144. Vaz, M., Jennings, G., Turner, A., Cox, H., Lambert, G. & Esler, M. 1997. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation 96, 3423–3429.
145. Wadei, H.M. & Textor, S.C. 2012. The role of the kidney in regulating arterial blood pressure. Nat Rev Nephrol 8, 602–609.
146. Wallin, B.G., Esler, M., Dorward, P., Eisenhofer, G., Ferrier, C., Westerman, R. & Jennings, G. 1992. Simultaneous measurements of cardiac noradrenaline spillover and sympathetic outflow to skeletal muscle in humans. J Physiol 453, 45–58.
147. Wallin, B.G., Kunimoto, M.M. & Sellgren, J. 1993. Possible genetic influence on the strength of human muscle nerve sympathetic activity at rest. Hypertension 22, 282–284.
148. Walser, M. 1985. Phenomenological analysis of renal regulation of sodium and potassium balance. Kidney Int 27, 837–841.
149. Williams, G.H., Rose, L.I., Dluhy, R.G., McCaughn, D., Jagger, P.I., Hickler, R.B. & Lauler, D.P. 1970. Abnormal responsiveness of the renin aldosterone system to acute stimulation in patients with essential hypertension. Ann Intern Med 72, 317–326.
150. Williams, G.H., Tuck, M.L., Sullivan, J.M., Dluhy, R.G. & Hollenberg, N.K. 1982. Parallel adrenal and renal abnormalities in young patients with essential hypertension. Am J Med 72, 907–914.
151. Williams, G.H., Moore, T.J. & Hollenberg, N.K. 1991. Dysregulation of aldosterone secretion and its relationship to the pathogenesis of essential hypertension. Endocrinol Metab Clin North Am 20, 423–447.